Brief: Rakovina Therapeutics Announces Initial Drug Candidates From Deep Docking Ai Molecule Discovery Platform
23/10/2024 13:36
Oct 23 (Reuters) - Rakovina Therapeutics Inc RKV.V :
* RAKOVINA THERAPEUTICS ANNOUNCES INITIAL DRUG CANDIDATES
FROM
DEEP DOCKING AI MOLECULE DISCOVERY PLATFORM
Source text for Eikon: ID:nGNX8WkXLG
Further company coverage: RKV.V
((Reuters.Briefs@thomsonreuters.com))
Recent news on Rakovina Therapeutics
See all newsBrief: Rakovina Therapeutics Announces Three-Month Q2 Ended June 30, 2025 Financial Results And Provides Corporate Update
Brief: Rakovina Therapeutics Announces The Closing Of Oversubscribed Private Placement Of $4.9 Million
Brief: Rakovina Therapeutics Appoints David Kideckel As Chief Financial Officer
Brief: Rakovina Therapeutics Announces 2024 Financial Results
Brief: Rakovina Therapeutics Announces Successful Synthesis Of Novel Small-Molecule Drug Candidates Designed Under AI Platform Collaboration